Levetiracetam 1a Farma

Levetiracetam, the active ingredient in Levetiracetam 1a Farma, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed to manage various seizure types in patients diagnosed with epilepsy, including partial and generalized tonic‑clonic seizures. It helps reduce neuronal excitability by targeting synaptic vesicle protein SV2A.

GNH USA supplies Levetiracetam 1a Farma as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to EU quality standards and providing the product to hospitals, pharmacies and clinics worldwide through regulated distribution channels.

Levetiracetam is an antiepileptic medication used to control seizure activity in various forms of epilepsy. - Partial seizures: decreases the frequency of focal onset seizures, with or without secondary generalization. - Generalized tonic‑clonic seizures: helps prevent the occurrence of primary generalized convulsive seizures. - Epilepsy (overall seizure control): contributes to overall reduction in seizure burden as part of a comprehensive treatment plan.

Levetiracetam may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Somnolence: increased sleepiness or fatigue. - Headache: mild to moderate cranial pain. - Irritability: mood changes including agitation. - Nausea: occasional upset stomach. - Fatigue: general lack of energy.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare but serious skin disorder. - Suicidal thoughts or behavior: new or worsening depression. - Severe skin rash: extensive erythema or blistering. - Blood dyscrasias: neutropenia or thrombocytopenia. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

When prescribing levetiracetam, clinicians should consider several safety aspects. - Dose adjustment in renal impairment: modify dose based on creatinine clearance. - Monitor for mood changes: watch for depression or suicidal ideation. - Avoid abrupt discontinuation: taper under medical supervision to prevent seizure worsening. - Use caution in pregnancy: limited data, assess risk versus benefit. - Store at ambient temperature: keep below 25°C, protect from moisture and light in the original container.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Concomitant use with carbamazepine: may reduce levetiracetam plasma levels. - Co‑administration with enzyme‑inducing antiepileptics (phenytoin, phenobarbital): may decrease efficacy. - Strong inhibitors of renal tubular secretion (e.g., probenecid): may increase levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Combination with other CNS depressants (benzodiazepines, alcohol): may enhance sedation. - Use with antidepressants (SSRIs): monitor for behavioral changes.